Insitutional Investors
The company is financed by premier technology and life sciences investors, including:
Accel Partners
Three Arch Partners
Bay City Capital
Morgan Stanley Capital Partners
Oracle Venture Fund
In addition, the company has received strategic investments from partners such as Millennium Pharmaceuticals and Affymetrix Corporation.
Select Individual Investors
Stephen Fodor, Ph.D. - Chairman and CEO, Affymetrix, Inc.
Edward Penhoet, Ph.D. - Retired Co-Founder, President and CEO, Chiron Corporation
George Poste, Ph.D. - Director, Arizona Biodesign Institute
Lubert Stryer, Ph.D. - Professor of Neurobiology, Stanford University
John A. Young - Retired CEO, Hewlett Packard
Alejandro Zaffaroni, Ph.D. - Director Emeritus and Co-Founder, Alza Corporation
|
